precocious puberty
Recently Published Documents


TOTAL DOCUMENTS

2649
(FIVE YEARS 189)

H-INDEX

67
(FIVE YEARS 0)

2022 ◽  
Vol 5 (1) ◽  
pp. 01-05
Author(s):  
Satesh Bidaisee ◽  
Stephanie Y. Huang ◽  
Siriluk Pichainarongk

Precocious puberty, otherwise described as a group of medical conditions that cause early puberty onset, such as a pre-adolescent boy presenting with adult pattern of penile and testicular enlargement or a pre-adolescent girl presenting with mature breast development and onset of menses. Although the sexual and physical characteristics for this condition are well-described in medical literature, the causes are very rarely known. Nevertheless, it has substantial impacts on children’s lives. This is a review on sexual development, premature sexual development, the social complications children suffer from due to early onset puberty, and the associations with daily environmental exposures as possible influences for developing precocious puberty.





Author(s):  
Tülin Köksal ◽  
Sıddıka Songül Yalçin ◽  
Seyit Ahmet Uçartürk


2022 ◽  
Author(s):  
Recep Polat ◽  
Erdem Çokluk ◽  
Özcan Budak ◽  
Fatıma Betül Tuncer

Abstract Introduction: Nutrition and exposure to various chemicals, including environmental pollution, insecticides, and plant phytoestrogens (having oestrogen-like effects), are environmental factors that affect puberty onset. We aimed to identify the effects of propolis on precocious puberty and the reproductive system in prepubertal female rats (ovary, endometrium, breast).Methods: Thirty-four 25-day-old prepubertal female Sprague-Dawley rats were included in the study. Rats were randomly divided into the propolis (n 17) and control groups (n 17). The primary endpoint was the number of rats that developed vaginal opening (It's a sign of puberty) at 12-day follow-up. In addition, the effect of propolis on ovary, uterus and breast tissue was evaluated.Results: Vaginal patency occurred earlier in the propolis group. At the same time, a greater number of rats developed vaginal opening. The number of ovarian follicles (in all follicles), endometrial thickness, and mammary gland secretory gland area were significantly higher in the propolis group than in the control group (p-values <0.001, <0.001, <0.001, respectively). In addition, Ki-67 activity in the endometrium, breast tissue and ovary was more intense in the propolis group compared to the control group (p-values <0.001, <0.001, <0.001, respectively).Conclusion: Propolis triggers precocious puberty in female rats, possibly by interacting with the oestrogen receptor. The mechanism of action of propolis should be considered before prescribing it. In addition, further studies are needed to explore the mechanism of action of propolis and to determine the component of propolis that triggers puberty.



Author(s):  
Douglas Villalta ◽  
Jose Bernardo Quintos

Abstract Gonadotropin releasing hormone analogs (GnRHas) are an effective treatment to address the compromise in height potential seen in patients with central precocious puberty. There is no evidence in the literature of a single GnRHa used for longer than 2 years before being removed or replaced. We describe a patient who was on continuous gonadotropin suppression for 7 years and despite this, achieved a height potential within one standard deviation of mid-parental height. A boy aged 10 years and 3 months presented to endocrine clinic with signs of precocious puberty and advanced bone age. Initial labs showed random LH 9.4 mIU/mL, FSH 16.3 mIU/mL, DHEAS 127 mcg/dl, and testosterone 628 ng/dL. He was initially started on Lupron injections before transitioning to a Histrelin implant. Follow-up laboratory results 5 months post-suppression showed pre-pubertal random LH 0.2 mIU/mL, FSH 0.1 mIU/mL, and testosterone 5 ng/dL. The patient was lost to follow-up and returned 5 years later presenting with gynecomastia and delayed bone age. He had continuous gonadotropin suppression with random LH 0.10 mIU/mL, FSH 0.16 mIU/mL, and testosterone 8 ng/dL. The Histrelin implant was removed and 4 months after removal labs showed random pubertal hormone levels with LH 5.6 mIU/mL, FSH 4.3 mIU/mL, and testosterone 506 ng/dl. The patient’s mid-parental height was 175.3 cm and the patient’s near final height was 170.6 cm which is within one standard deviation of his genetic potential. Further studies are needed to explore continuous gonadotropin hormone suppression with a single Histrelin implant beyond 2 years.



2022 ◽  
Vol 2022 ◽  
pp. 1-4
Author(s):  
C. R. Naotunna ◽  
D. N. Siriwardana ◽  
B. C. Lakmini ◽  
M. Samarasinghe ◽  
N. Atapattu

Leydig cell tumors, most often benign, are a rare cause of isosexual gonadotropin-independent precocious puberty in boys due to secretion of testosterone. Very rarely do these tumors produce estrogen, causing gynecomastia. Testicular sparing surgery is the mainstay of treatment currently although radical orchidectomy was the choice in the past. Following surgery, clinical signs improve along with a revision of biochemical changes. Occasionally, it has been reported few children are progressed to gonadotropin-dependent precocious puberty (GDPP) after initial clinical and biochemical recovery. Gonadotropin receptor analogs have been successful on them to halt the progression of puberty, and growth hormone administration has been used to optimize the adult height. Here, we report a case of a 10-year-old boy who presented very late due to failure in recognition of features of puberty due to a Leydig cell tumor. Even though he underwent successful radical orchidectomy, just within 1 month following surgery, he entered GDPP in contrast to the published cases where it was earliest detected at 3 months.



2022 ◽  
Author(s):  
Laura Chioma ◽  
Carla Bizzarri ◽  
Martina Verzani ◽  
Daniela Fava ◽  
Mariacarolina Salerno ◽  
...  

Objective: This retrospective study aimed to evaluate children observed for suspected precocious puberty in 5 Italian centers of Pediatric Endocrinology during the first wave of COVID-19 pandemic (March- September 2020), compared to subjects observed in the same period of the previous year. Design: The study population (490 children) was divided according to year of observation and final diagnosis: transient thelarche (TT), non-progressive precocious puberty (NPP), central precocious puberty (CPP), or early puberty (EP). Results: Between March and September 2020, 338 subjects were referred for suspected precocious puberty, compared to 152 subjects in the same period of 2019 (+222%). The increase was observed in girls (328 subjects in 2020 versus 140 in 2019, p<0.05), especially during the second half of the period considered (92 girls from March to May versus 236 girls from June to September); while no difference was observed in boys (10 subjects in 2020 versus 12 in 2019). The percentage of girls with confirmed CPP was higher in 2020, compared to 2019 (135/328 girls [41%] versus 37/140 [26%], p<0.01). Anthropometric and hormonal parameters in 2019 and 2020 CPP girls were not different; 2020 CPP girls showed a more prolonged use of electronic devices and a more sedentary lifestyle both before and during the pandemic, compared to the rest of the 2020 population. Conclusions: The present findings corroborate the recently reported association between the complex lifestyle changes related to the lockdown and a higher incidence of central precocious puberty in Italian girls.



Author(s):  
Marina López-Miralles ◽  
Laura Lacomba-Trejo ◽  
Selene Valero-Moreno ◽  
Gemma Benavides ◽  
Marián Pérez-Marín


Sign in / Sign up

Export Citation Format

Share Document